Paper806263
BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
Wald ER and 4 others. Antimicrob Agents Chemother, 1975. Cited by 38 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa. Papers, record 806263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/806263
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbenicillin | Major topic |
| Gentamicins | Major topic |
| Penicillins | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Ticarcillin | Major topic |
| Drug Combinations | |
| Guanidines | |
| Penicillanic Acid |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,157,342 | Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4157342 | PubMed |
| 2 | 5,000,263 | -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vitro evaluation. | Antimicrob Agents Chemother (Bethesda) | 1970 | https://conductscience.org/library/papers/5000263 | PubMed |
| 3 | 4,180,218 | Resistance of Pseudomonas aeruginosa to carbenicillin. | Lancet | 1969 | https://conductscience.org/library/papers/4180218 | PubMed |
| 4 | 4,407,110 | The hemostatic defect produced by carbenicillin. | N Engl J Med | 1974 | https://conductscience.org/library/papers/4407110 | PubMed |
| 5 | 4,711,781 | Carbenicillin and hypokalemia. | Ann Intern Med | 1973 | https://conductscience.org/library/papers/4711781 | PubMed |
| 6 | 4,989,316 | Carbenicillin: a clinical and laboratory evaluation. | Ann Intern Med | 1970 | https://conductscience.org/library/papers/4989316 | PubMed |
| 7 | 4,959,982 | Simplified, accurate method for antibiotic assay of clinical specimens. | Appl Microbiol | 1966 | https://conductscience.org/library/papers/4959982 | PubMed |
| 8 | 4,897,133 | Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. | Medicine (Baltimore) | 1969 | https://conductscience.org/library/papers/4897133 | PubMed |
| 9 | 4,924,999 | In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillin. | Appl Microbiol | 1971 | https://conductscience.org/library/papers/4924999 | PubMed |
| 10 | 4,871,700 | The importance of underlying disease in patients with gram-negative bacteremia. | Arch Intern Med | 1968 | https://conductscience.org/library/papers/4871700 | PubMed |
| 11 | 6,061,541 | Gram-negative septicemia: a growing threat. | Ann Surg | 1967 | https://conductscience.org/library/papers/6061541 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19,564,363 | Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19564363 | PubMed |
| 7,002,527 | Ticarcillin: a review of its pharmacological properties and therapeutic efficacy. | Drugs | 1980 | https://conductscience.org/library/papers/7002527 | PubMed |
| 6,225,391 | Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6225391 | PubMed |
| 3,311,531 | Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311531 | PubMed |
| 3,300,527 | Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3300527 | PubMed |
| 3,069,193 | Antibiotic combinations: should they be tested? | Clin Microbiol Rev | 1988 | https://conductscience.org/library/papers/3069193 | PubMed |
| 2,113,159 | Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram. | Med Microbiol Immunol | 1990 | https://conductscience.org/library/papers/2113159 | PubMed |
| 984,764 | Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984764 | PubMed |
| 938,027 | Laboratory studies with a new broad-spectrum penicillin, pirbenicillin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/938027 | PubMed |
| 817,659 | Evaluation of antibiotic efficacy using electron microscopy: morphological effects of guanylureido cephalosporin, chlorobenzoylureido cephalosporin, BL-P1654, and carbenicillin on Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/817659 | PubMed |
| 816,248 | Comparative in vitro evaluation of the effects of ticarcillin and carbenicillin upon Psuedomonas aeruginosa. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/816248 | PubMed |
| 795,373 | In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/795373 | PubMed |
| 795,372 | Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/795372 | PubMed |
| 406,837 | Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/406837 | PubMed |
| 404,963 | Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/404963 | PubMed |
| 397,937 | [Fifty years of penicillins. A review of structure-effect relationships of beta-lactamase antibiotics and their microbiological and clinical relevance (author's transl)]. | Infection | 1979 | https://conductscience.org/library/papers/397937 | PubMed |
| 98,109 | In vitro antibacterial activity of amikacin and ticarcillin, alone and in combination, against Pseudomonas aerurginosa. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/98109 | PubMed |
| 96,736 | Unpredictable response of Pseudomonas aeruginosa to synergistic antibiotic combinations in vitro. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/96736 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/806263
GET https://conductscience.org/api/papers/v1/806263/authors